<span item_type="fundamental" item_id="bbbfa04cdc7a8851dae21fbb913f37ce" counter_id="ST/US/VMCWF" env="prod"></span><span item_type="announcement" item_id="549080209167418113" env="prod"></span><p>EPS: As of FY2025 Q2, the actual value is USD 0.01.</p><p></p><h3>Segment Revenue</h3><ul><li>The company has not commenced any operations and therefore has not generated any operating revenue as of June 30, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1892747/000164117225023470/form10-q.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>For the three months ended June 30, 2025, the company reported a net income of $58,716, primarily due to interest earned on investments held in the Trust Account amounting to $185,332, offset by operating costs of $126,616.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1892747/000164117225023470/form10-q.htm"></span></li><li>For the six months ended June 30, 2025, the company reported a net income of $83,692, with interest income of $366,679 and operating costs of $282,987.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1892747/000164117225023470/form10-q.htm"></span></li><li>For the three months ended June 30, 2024, the company reported a net income of $168,692, with interest income of $634,492 and general and administrative expenses of $465,800.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1892747/000164117225023470/form10-q.htm"></span></li><li>For the six months ended June 30, 2024, the company reported a net income of $757,373, with interest income of $1,480,642 and general and administrative expenses of $723,269.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1892747/000164117225023470/form10-q.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>Net cash used in operating activities for the six months ended June 30, 2025, was - $268,397, compared to - $518,687 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1892747/000164117225023470/form10-q.htm"></span></li><li>Net cash used in investing activities for the six months ended June 30, 2025, was - $140,055, compared to $49,284,357 provided by investing activities for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1892747/000164117225023470/form10-q.htm"></span></li><li>Net cash provided by financing activities for the six months ended June 30, 2025, was $440,076, compared to - $49,430,380 used in financing activities for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1892747/000164117225023470/form10-q.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li>The company has a working capital deficit of $4,652,885 as of June 30, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1892747/000164117225023470/form10-q.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company intends to use the funds held in the Trust Account to complete a Business Combination, with a focus on identifying a target company in Asia (excluding China, Hong Kong, and Macau) that is developing breakthrough technology in life sciences or sustainable technology.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1892747/000164117225023470/form10-q.htm"></span></li><li><strong>Non-Core Business</strong>: The company has extended the date by which it must consummate a Business Combination multiple times, with the current deadline set for March 3, 2026, if further extensions are elected.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1892747/000164117225023470/form10-q.htm"></span></li><li><strong>Priority</strong>: The company is focused on completing a Business Combination and has issued convertible promissory notes to fund working capital needs and extend the Combination Period.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1892747/000164117225023470/form10-q.htm"></span></li></ul>

VALUENCE MERGER CORP I C/WTS 18/02/2027 (TO PUR COM) | 10-Q: FY2025 Q2 EPS: USD 0.01